Senate GOP Victories Leave Frist As First Among Equals On Health Issues
Executive Summary
The Senate Finance Committee would add a staunch supporter of a private competition-based prescription drug program under Medicare if Sen. Bill Frist (R-Tenn.) is appointed to the committee
You may also be interested in...
Generic Drug Reform Outlook: Medicare Rx Bill May Be Best Vehicle
The best opportunity to push Waxman/Hatch reforms in the next Congress will likely be in the context of a Medicare prescription drug benefit bill
Senate Change Puts Hatch, Gregg, Grassley In Line For Key Rx Committees
The transfer of control in the Senate puts Sen. Orrin Hatch (R-Utah) in position to have greater influence in guiding generic drug reform legislation
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011